5-Chloro-3-(methylthio)-1,2,4-thiadiazole

Catalog No. :
ACEEJN850
CAS No. :
21735-15-9
Molecular Formula :
C3H3ClN2S2
Molecular Weight :
166.66

IUPAC Name:5-chloro-3-(methylthio)-1,2,4-thiadiazole

5-Chloro-3-(methylthio)-1,2,4-thiadiazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$92.00Login to see priceInquiryInquiry
100mg95%$127.00Login to see priceInquiryInquiry
250mg95%$173.00Login to see priceInquiryInquiry
1g95%$331.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Chloro-3-(methylthio)-1,2,4-thiadiazole
IUPAC Name5-chloro-3-(methylthio)-1,2,4-thiadiazole
MDL No.MFCD07779433
Molecular FormulaC3H3ClN2S2
Molecular Weight166.66
SMILESCSC1=NSC(Cl)=N1
InChI KeyIFRYKIFAMMXTOF-UHFFFAOYSA-N
Synonym3-(Methylthio)-5-chloro-1,2,4-thiadiazole;5-Chloro-3-(methylthio)-1,2,4-thiadiazole;5-Chloro-3-methylmercapto-1,2,4-thiadiazole;1,2,4-Thiadiazole, 5-chloro-3-(methylthio)-
CAS No.21735-15-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACEEJN850 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPSBA043 route compound structure diagram
    ACPSBA0432254-88-8 In Stock
  4. Then
  5. ACEEJN850 route product structure diagram
    ACEEJN85021735-15-9
Inquiry

2. ACEEJN850 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPSBA043 route compound structure diagram
    ACPSBA0432254-88-8 In Stock
  4. Then
  5. ACEEJN850 route product structure diagram
    ACEEJN85021735-15-9
Inquiry

Comments (0)